Pharmacokinetic Changes during Pregnancy According to Genetic Variants: A Prospective Study in HIV-infected Patients Receiving Atazanavir/Ritonavir
2018-01-01 Focà, Emanuele; Calcagno, Andrea; Bonito, Andrea; Cusato, Jessica; Domenighini, Elisabetta; D'Avolio, Antonio; Roldan, Eugenia Quiros; Trentini, Laura; Castelnuovo, Filippo; Perri, Giovanni Di; Castelli, Francesco; Bonora, Stefano
What do we know about tailoring treatment with tenofovir?
2016-01-01 Calcagno, Andrea; Di Perri, Giovanni; Bonora, Stefano
Pharmacokinetics of caspofungin increased dosage in a patient on rifampin-containing anti-tubercular treatment
2013-01-01 Calcagno, Andrea; Baietto, Lorena; Pagani, N; Bertucci, R; Rostagno, R; D'Avolio, Antonio; Di Perri, Giovanni; De Rosa, Francesco Giuseppe
Efficacy, Tolerability and Virological Consequences of Long-term Use of Unboosted Atazanavir plus 2 NRTIs in HIV-infected Patients
2014-01-01 Bonora, Stefano; Calcagno, Andrea; Vigano, O; Bigliano, P; Marinaro, L; Colella, E; Orofino, G; Trentini, L; Tettoni, Mc; D'Avolio, Antonio; Mercadante, S; Galli, M; Di Perri, Giovanni; Rusconi, S.
Latent tuberculosis infection screening in persons newly-diagnosed with HIV infection in Italy: A multicentre study promoted by the Italian Society of Infectious and Tropical Diseases
2020-01-01 Goletti, D.; Navarra, A.; Petruccioli, E.; Cimaglia, C.; Compagno, M.; Cuzzi, G.; De Carli, G.; Fondaco, L.; Franzetti, F.; Giannetti, A.; Gori, A.; Lapadula, G.; Lichtner, M.; Mastroianni, C. M.; Mazzotta, V.; Orchi, N.; Pavone, P.; Piacentini, D.; Pirriatore, V.; Pontali, E.; Sarmati, L.; Spolti, A.; Tacconelli, E.; Galli, M.; Antinori, A.; Calcagno, A.; Girardi, E.
CNS-Targeted Antiretroviral Strategies: When Are They Needed and What to Choose
2018-01-01 Calcagno, Andrea; Barco, Ambra; Trunfio, Mattia; Bonora, Stefano
Low antituberculosis drug concentrations in HIV-tuberculosis-coinfected adults with low body weight: Is it time to update dosing guidelines?
2019-01-01 Sekaggya-Wiltshire, C.; Chirehwa, M.; Musaazi, J.; Von Braun, A.; Buzibye, A.; Muller, D.; Gutteck, U.; Motta, I.; Calcagno, A.; Fehr, J. S.; Kambugu, A.; Castelnuovo, B.; Lamorde, M.; Denti, P.
The presence of resistance-associated mutations in reverse transcriptase gene is associated with cerebrospinal fluid HIV-1 escape: A multicentric retrospective analysis
2023-01-01 Trunfio, Mattia; Pinnetti, Carmela; Arsuffi, Stefania; Bai, Francesca; Celani, Luigi; D'Ettorre, Gabriella; Vera, Jaime H; D'Arminio Monforte, Antonella; Focà, Emanuele; Ghisetti, Valeria; Bonora, Stefano; Antinori, Andrea; Calcagno, Andrea
Vitamin D as Modulator of Drug Concentrations: A Study on Two Italian Cohorts of People Living with HIV Administered with Efavirenz
2021-01-01 Cusato, Jessica; Tempestilli, Massimo; Calcagno, Andrea; Vergori, Alessandra; Piselli, Pierluca; Antonucci, Miriam; Avataneo, Valeria; Palermiti, Alice; Notari, Stefania; Antinori, Andrea; Di Perri, Giovanni; Agrati, Chiara; D’Avolio, Antonio
Analytical validation and clinical application of rapid serological tests for sars-cov-2 suitable for large-scale screening
2021-01-01 De Nicolò, Amedeo.; Avataneo, V.; Cusato, J.; Palermiti, A.; Mula, J.; De Vivo, E.; Antonucci, M.; Bonora, S.; Calcagno, A.; Di Perri, G.; De Rosa, F. G.; D'Avolio, A.
Raltegravir plus Nevirapine as Maintenance Antiretroviral Therapy in HIV-positive Patients: Safety, Efficacy and Pharmacokinetics
2016-01-01 Calcagno, Andrea; Montrucchio, Chiara; Capetti, Adila; Guaraldi, G; Cenderello, G; Calza, L; Lanzafame, M; Marinaro, Letizia; Tettoni, M. C; Trentini, Laura; D'Avolio, Antonio; Di Perri, Giovanni; Bonora, Stefano
Rifampicin and Isoniazid Maximal Concentrations are Below Efficacy-associated Thresholds in the Majority of Patients: Time to Increase the Doses?
2021-01-01 Trentalange, Alice; Borgogno, Enrica; Motta, Ilaria; Antonucci, Miriam; Pirriatore, Veronica; Costa, Cecilia; Rossi, Giovanni; Barco, Ambra; De Nicolò, Amedeo; Piccioni, Pavilio; D'Avolio, Antonio; Bonora, Stefano; Perri, Giovanni Di; Calcagno, Andrea
Comment on “Higher CNS Penetration-Effectiveness of Long-Term Combination Antiretroviral Therapy is Associated With Better HIV-1 Viral Suppression in Cerebrospinal Fluid”
2013-01-01 Calcagno, Andrea; D'Avolio, Antonio; Di Perri, Giovanni; Bonora, Stefano
BCGitis after Bacille Calmette-Guerin intravesical administration from two referral centers: clinical characteristics and risk factors
2022-01-01 De Benedetto, Ilaria; Barco, Ambra; Rossi, Marianna; Lapadula, Giuseppe; Lupia, Tommaso; Bonfanti, Paolo; Bonora, Stefano; Di Perri, Giovanni; Calcagno, Andrea
Clinical phenotype and contagiousness of early breakthrough SARS-CoV-2 infections after BNT162b2 COVID-19 mRNA vaccine: A parallel cohort study in healthcare workers
2021-01-01 Trunfio, M.; Verga, F.; Ghisetti, V.; Burdino, E.; Emanuele, T.; Bonora, S.; Di Perri, G.; Calcagno, A.
A LC-MS method to quantify tenofovir urinary concentrations in treated patients
2015-01-01 Simiele, Marco; Carcieri, Chiara; De Nicolo', Amedeo; Ariaudo, Alessandra; Sciandra, Mauro; Calcagno, Andrea; Bonora, Stefano; Di Perri, Giovanni; D'Avolio, Antonio
High interpatient variability of raltegravir CSF concentrations in HIV-positive patients: a pharmacogenetic analysis
2014-01-01 Calcagno, Andrea; Cusato, Jessica; Simiele, Marco; Motta, Ilaria; Audagnotto, S; Bracchi, M; D'Avolio, Antonio; Di Perri, Giovanni; Bonora, Stefano
Elderly HIV-positive women: A gender-based analysis from the Multicenter Italian “GEPPO” Cohort
2019-01-01 Foca, E.; Magro, P.; Guaraldi, G.; Riva, A.; Cattelan, A. M.; De Socio, G. V.; Costa, C.; Piconi, S.; Celesia, B. M.; Nozza, S.; Orofino, G.; Castagna, A.; Di Perri, G.; Castelli, F.; Calcagno, A.
Raltegravir penetration in the cerebrospinal fluid of HIV-positive patients
2010-01-01 Calcagno, Andrea; Bonora, Stefano; R., Bertucci; A., Lucchini; D'Avolio, Antonio; Di Perri, Giovanni
Pharmacokinetics of an antiretroviral regimen in a patient unable to swallow solid oral dosage forms
2016-01-01 Patti, Francesca; Calcagno, Andrea; Simiele, Marco; Bonasso, Marino; Di Perri, Giovanni; D'Avolio, Antonio; Bonora, Stefano
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Pharmacokinetic Changes during Pregnancy According to Genetic Variants: A Prospective Study in HIV-infected Patients Receiving Atazanavir/Ritonavir | 1-gen-2018 | Focà, Emanuele; Calcagno, Andrea; Bonito, Andrea; Cusato, Jessica; Domenighini, Elisabetta; D'Avolio, Antonio; Roldan, Eugenia Quiros; Trentini, Laura; Castelnuovo, Filippo; Perri, Giovanni Di; Castelli, Francesco; Bonora, Stefano | |
| What do we know about tailoring treatment with tenofovir? | 1-gen-2016 | Calcagno, Andrea; Di Perri, Giovanni; Bonora, Stefano | |
| Pharmacokinetics of caspofungin increased dosage in a patient on rifampin-containing anti-tubercular treatment | 1-gen-2013 | Calcagno, Andrea; Baietto, Lorena; Pagani, N; Bertucci, R; Rostagno, R; D'Avolio, Antonio; Di Perri, Giovanni; De Rosa, Francesco Giuseppe | |
| Efficacy, Tolerability and Virological Consequences of Long-term Use of Unboosted Atazanavir plus 2 NRTIs in HIV-infected Patients | 1-gen-2014 | Bonora, Stefano; Calcagno, Andrea; Vigano, O; Bigliano, P; Marinaro, L; Colella, E; Orofino, G; Trentini, L; Tettoni, Mc; D'Avolio, Antonio; Mercadante, S; Galli, M; Di Perri, Giovanni; Rusconi, S. | |
| Latent tuberculosis infection screening in persons newly-diagnosed with HIV infection in Italy: A multicentre study promoted by the Italian Society of Infectious and Tropical Diseases | 1-gen-2020 | Goletti, D.; Navarra, A.; Petruccioli, E.; Cimaglia, C.; Compagno, M.; Cuzzi, G.; De Carli, G.; Fondaco, L.; Franzetti, F.; Giannetti, A.; Gori, A.; Lapadula, G.; Lichtner, M.; Mastroianni, C. M.; Mazzotta, V.; Orchi, N.; Pavone, P.; Piacentini, D.; Pirriatore, V.; Pontali, E.; Sarmati, L.; Spolti, A.; Tacconelli, E.; Galli, M.; Antinori, A.; Calcagno, A.; Girardi, E. | |
| CNS-Targeted Antiretroviral Strategies: When Are They Needed and What to Choose | 1-gen-2018 | Calcagno, Andrea; Barco, Ambra; Trunfio, Mattia; Bonora, Stefano | |
| Low antituberculosis drug concentrations in HIV-tuberculosis-coinfected adults with low body weight: Is it time to update dosing guidelines? | 1-gen-2019 | Sekaggya-Wiltshire, C.; Chirehwa, M.; Musaazi, J.; Von Braun, A.; Buzibye, A.; Muller, D.; Gutteck, U.; Motta, I.; Calcagno, A.; Fehr, J. S.; Kambugu, A.; Castelnuovo, B.; Lamorde, M.; Denti, P. | |
| The presence of resistance-associated mutations in reverse transcriptase gene is associated with cerebrospinal fluid HIV-1 escape: A multicentric retrospective analysis | 1-gen-2023 | Trunfio, Mattia; Pinnetti, Carmela; Arsuffi, Stefania; Bai, Francesca; Celani, Luigi; D'Ettorre, Gabriella; Vera, Jaime H; D'Arminio Monforte, Antonella; Focà, Emanuele; Ghisetti, Valeria; Bonora, Stefano; Antinori, Andrea; Calcagno, Andrea | |
| Vitamin D as Modulator of Drug Concentrations: A Study on Two Italian Cohorts of People Living with HIV Administered with Efavirenz | 1-gen-2021 | Cusato, Jessica; Tempestilli, Massimo; Calcagno, Andrea; Vergori, Alessandra; Piselli, Pierluca; Antonucci, Miriam; Avataneo, Valeria; Palermiti, Alice; Notari, Stefania; Antinori, Andrea; Di Perri, Giovanni; Agrati, Chiara; D’Avolio, Antonio | |
| Analytical validation and clinical application of rapid serological tests for sars-cov-2 suitable for large-scale screening | 1-gen-2021 | De Nicolò, Amedeo.; Avataneo, V.; Cusato, J.; Palermiti, A.; Mula, J.; De Vivo, E.; Antonucci, M.; Bonora, S.; Calcagno, A.; Di Perri, G.; De Rosa, F. G.; D'Avolio, A. | |
| Raltegravir plus Nevirapine as Maintenance Antiretroviral Therapy in HIV-positive Patients: Safety, Efficacy and Pharmacokinetics | 1-gen-2016 | Calcagno, Andrea; Montrucchio, Chiara; Capetti, Adila; Guaraldi, G; Cenderello, G; Calza, L; Lanzafame, M; Marinaro, Letizia; Tettoni, M. C; Trentini, Laura; D'Avolio, Antonio; Di Perri, Giovanni; Bonora, Stefano | |
| Rifampicin and Isoniazid Maximal Concentrations are Below Efficacy-associated Thresholds in the Majority of Patients: Time to Increase the Doses? | 1-gen-2021 | Trentalange, Alice; Borgogno, Enrica; Motta, Ilaria; Antonucci, Miriam; Pirriatore, Veronica; Costa, Cecilia; Rossi, Giovanni; Barco, Ambra; De Nicolò, Amedeo; Piccioni, Pavilio; D'Avolio, Antonio; Bonora, Stefano; Perri, Giovanni Di; Calcagno, Andrea | |
| Comment on “Higher CNS Penetration-Effectiveness of Long-Term Combination Antiretroviral Therapy is Associated With Better HIV-1 Viral Suppression in Cerebrospinal Fluid” | 1-gen-2013 | Calcagno, Andrea; D'Avolio, Antonio; Di Perri, Giovanni; Bonora, Stefano | |
| BCGitis after Bacille Calmette-Guerin intravesical administration from two referral centers: clinical characteristics and risk factors | 1-gen-2022 | De Benedetto, Ilaria; Barco, Ambra; Rossi, Marianna; Lapadula, Giuseppe; Lupia, Tommaso; Bonfanti, Paolo; Bonora, Stefano; Di Perri, Giovanni; Calcagno, Andrea | |
| Clinical phenotype and contagiousness of early breakthrough SARS-CoV-2 infections after BNT162b2 COVID-19 mRNA vaccine: A parallel cohort study in healthcare workers | 1-gen-2021 | Trunfio, M.; Verga, F.; Ghisetti, V.; Burdino, E.; Emanuele, T.; Bonora, S.; Di Perri, G.; Calcagno, A. | |
| A LC-MS method to quantify tenofovir urinary concentrations in treated patients | 1-gen-2015 | Simiele, Marco; Carcieri, Chiara; De Nicolo', Amedeo; Ariaudo, Alessandra; Sciandra, Mauro; Calcagno, Andrea; Bonora, Stefano; Di Perri, Giovanni; D'Avolio, Antonio | |
| High interpatient variability of raltegravir CSF concentrations in HIV-positive patients: a pharmacogenetic analysis | 1-gen-2014 | Calcagno, Andrea; Cusato, Jessica; Simiele, Marco; Motta, Ilaria; Audagnotto, S; Bracchi, M; D'Avolio, Antonio; Di Perri, Giovanni; Bonora, Stefano | |
| Elderly HIV-positive women: A gender-based analysis from the Multicenter Italian “GEPPO” Cohort | 1-gen-2019 | Foca, E.; Magro, P.; Guaraldi, G.; Riva, A.; Cattelan, A. M.; De Socio, G. V.; Costa, C.; Piconi, S.; Celesia, B. M.; Nozza, S.; Orofino, G.; Castagna, A.; Di Perri, G.; Castelli, F.; Calcagno, A. | |
| Raltegravir penetration in the cerebrospinal fluid of HIV-positive patients | 1-gen-2010 | Calcagno, Andrea; Bonora, Stefano; R., Bertucci; A., Lucchini; D'Avolio, Antonio; Di Perri, Giovanni | |
| Pharmacokinetics of an antiretroviral regimen in a patient unable to swallow solid oral dosage forms | 1-gen-2016 | Patti, Francesca; Calcagno, Andrea; Simiele, Marco; Bonasso, Marino; Di Perri, Giovanni; D'Avolio, Antonio; Bonora, Stefano |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista35953
- 4 Contributo in Atti di Convegno ...1
Data di pubblicazione
- In corso di stampa66
- 2020 - 20269701
- 2010 - 201913033
- 2000 - 20097279
- 1990 - 19994152
- 1980 - 19891467
- 1970 - 1979232
- 1962 - 196924
Rivista
- PHYSICS LETTERS. SECTION B771
- JOURNAL OF HIGH ENERGY PHYSICS498
- PHYSICAL REVIEW LETTERS295
- THE EUROPEAN PHYSICAL JOURNAL. C,...284
- PHYSICAL REVIEW D234
- JOURNAL OF HIGH ENERGY PHYSICS183
- PLOS ONE181
- BLOOD169
- INTERNATIONAL JOURNAL OF MOLECULA...163
- NUCLEAR INSTRUMENTS & METHODS IN ...145
Keyword
- Humans1437
- Female757
- Male607
- Middle Aged459
- Adult415
- Aged406
- COVID-19342
- Italy297
- Animals217
- Treatment Outcome196
Lingua
- eng24603
- ita5264
- fre259
- spa169
- ger57
- rus29
- und26
- por17
- lat15
- grc6
Accesso al fulltext
- no fulltext21335
- reserved7297
- open4904
- restricted2301
- partially open90
- embargoed18
- mixed9